Myocarditis after RNA-based COVID-19 vaccines: Where do we stand?

Moroni, Francesco; Mbualungu, James; Abbate, Antonio

Moroni, Francesco; Mbualungu, James; Abbate, Antonio.

Moroni F; VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: francesco.moroni@vcuhealth.org.
Mbualungu J; VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.
Abbate A; VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.

Int J Cardiol ; 356: 81-82, 2022 06 01.

Article in English | MEDLINE | ID: covidwho-1734436

Subject(s)

COVID-19; Myocarditis; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Myocarditis/diagnosis; RNA; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Int J Cardiol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google